Intracoronary cardiosphere-derived cells after myocardial infarction: Evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-derived aUtologous stem CElls to reverse ventricular dysfunction)

Journal of the American College of Cardiology

Volumn 63, Issue 2, 2014, Pages 110-122

  Malliaras, Konstantinos ^a   Makkar, Raj R ^a   Smith, Rachel R ^a   Cheng, Ke ^a   Wu, Edwin ^b   Bonow, Robert O ^b   Marbán, Linda ^a   Mendizabal, Adam ^c   Cingolani, Eugenio ^a   Johnston, Peter V ^d   Gerstenblith, Gary ^d   Schuleri, Karl H ^d   Lardo, Albert C ^d,e   Marbán, Eduardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EMMES CORPORATION   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Johns Hopkins University   (United States)

Author keywords

cardiosphere derived cells; myocardial infarction; myocardial regeneration

Indexed keywords

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOSPHERE DERIVED AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOVASCULAR MAGNETIC RESONANCE; CELL THERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART VENTRICLE FUNCTION; HUMAN; IMAGING SYSTEM; INTRACORONARY DRUG ADMINISTRATION; NEW YORK HEART ASSOCIATION CLASS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

CARDIOSPHERE-DERIVED CELL; CARDIOSPHERE-DERIVED CELLS; CDC; CK-MB; COMPUTED TOMOGRAPHY; CREATINE KINASE-MYOCARDIAL BAND; CT; DATA AND SAFETY MONITORING BOARD; DSMB; ECC; EDV; EF; EJECTION FRACTION; END-DIASTOLIC VOLUME; END-SYSTOLIC VOLUME; ESV; FULL WIDTH AT HALF MAXIMUM; FWHM; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LEFT VENTRICULAR; LEFT VENTRICULAR EJECTION FRACTION; LV; LVEF; MAGNETIC RESONANCE IMAGING; MI; MRI; MYOCARDIAL INFARCTION; MYOCARDIAL REGENERATION; NEW YORK HEART ASSOCIATION; NYHA; OXYGEN CONSUMPTION; SAE; SERIOUS ADVERSE EVENT(S); SYSTOLIC CIRCUMFERENTIAL STRAIN; TNI; TROPONIN I; VO(2);

AGED; BIOPSY; CORONARY VESSELS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; INJECTIONS, INTRA-ARTERIAL; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84892394170     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.724     Document Type: Article

References (50)

1. E.S. Ford, U.A. Ajani, and J.B. Croft et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
2. H.D. White, P.E. Aylward, Z. Huang VALIANT Investigators Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Circulation 112 2005 3391 3399
3. S. Janssens, C. Dubois, and J. Bogaert et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 2006 113 121
4. K. Lunde, S. Solheim, and S. Aakhus et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction N Engl J Med 355 2006 1199 1209
5. G.P. Meyer, K.C. Wollert, and J. Lotz et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 2006 1287 1294
6. V. Schachinger, S. Erbs, and A. Elsasser et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 2006 1210 1221
7. J.M. Hare, J.H. Traverse, and T.D. Henry et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
8. J.H. Houtgraaf, W.K. den Dekker, and B.M. van Dalen et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 59 2012 539 540
9. V. Jeevanantham, M. Butler, A. Saad, A. Abdel-Latif, E.K. Zuba-Surma, and B. Dawn Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis Circulation 126 2012 551 568
10. R.R. Makkar, R.R. Smith, and K. Cheng et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial Lancet 379 2012 895 904
11. R.R. Smith, L. Barile, and H.C. Cho et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens Circulation 115 2007 896 908
12. Specialized Centers for Cell-based Therapy (SCCT): Sponsored by the National Heart, Lung and Blood Institute (NHLBI). Available at: http://www.sccelltherapy.net. Accessed January 23, 2013.
13. T.S. Rector, and J.N. Cohn Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group Am Heart J 124 1992 1017 1025
14. G.S. Slavin, and M. Saranathan FIESTA-ET: high-resolution cardiac imaging using echo-planar steady-state free precession Magn Reson Med 48 2002 934 941
15. K.H. Schuleri, M. Centola, and S.H. Choi et al. Multi-detector computed tomography for the evaluation of myocardial cell therapy in heart failure: a comparison with cardiac magnetic resonance imaging J Am Coll Cardiol Imaging 4 2011 1284 1293
16. E.A. Zerhouni, D.M. Parish, W.J. Rogers, A. Yang, and E.P. Shapiro Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion Radiology 169 1988 59 63
17. R.H. Helm, C. Leclercq, and O.P. Faris et al. Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronization Circulation 111 2005 2760 2767
18. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Int J Cardiovasc Imaging 18 2002 539 542
19. J. Garot, D.A. Bluemke, and N.F. Osman et al. Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI Circulation 101 2000 981 988
20. O.P. Simonetti, R.J. Kim, and D.S. Fieno et al. An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 2001 215 223
21. L.C. Amado, B.L. Gerber, and S.N. Gupta et al. Accurate and objective infarct sizing by contrast enhanced magnetic resonance imaging in a canine myocardial infarction model J Am Coll Cardiol 44 2004 2383 2389
22. E. Wu, J.T. Ortiz, and P. Tejedor et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart 94 2008 730 736
23. P.V. Johnston, T. Sasano, and K. Mills et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy Circulation 120 2009 1075 1083
24. K. Malliaras, T.S. Li, and D. Luthringer et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells Circulation 125 2012 100 112
25. M. Dominici, K. Le Blanc, and I. Mueller et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
26. R.A. Pelekanos, J. Li, and M. Gongora et al. Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities Stem Cell Res 8 2012 58 73
27. M. Ieda, T. Tsuchihashi, and K.N. Ivey et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling Dev Cell 16 2009 233 244
28. A.P. Beltrami, L. Barlucchi, and D. Torella et al. Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
29. E.C. Goldsmith, A. Hoffman, and M.O. Morales et al. Organization of fibroblasts in the heart Dev Dyn 230 2004 787 794
30. Y. Sun, and K.T. Weber Infarct scar: a dynamic tissue Cardiovasc Res 46 2000 250 256
31. S.M. Albelda, W.A. Muller, C.A. Buck, and P.J. Newman Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule J Cell Biol 114 1991 1059 1068
32. K. Cheng, K. Malliaras, and T.S. Li et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion Cell Transplant 21 2012 1121 1135
33. J. Quinn, N. Kramer, and D. McDermott Validation of the Social Security Death Index (SSDI): an important readily-available outcomes database for researchers West J Emerg Med 9 2008 6 8
34. A. Prasad, and J. Herrmann Myocardial infarction due to percutaneous coronary intervention N Engl J Med 364 2011 453 464
35. K. Malliaras, M. Kreke, and E. Marbán The stuttering progress of cell therapy for heart disease Clin Pharmacol Ther 90 2011 532 541
36. J. Greupner, E. Zimmermann, and A. Grohmann et al. Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard J Am Coll Cardiol 59 2012 1897 1907
37. A.R. Chugh, G.M. Beache, and J.H. Loughran et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance Circulation 126 Suppl 1 2012 S54 S64
38. M. Kreke, R.R. Smith, L. Marbán, and E. Marbán Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction Expert Rev Cardiovasc Ther 10 2012 1185 1194
39. R.J. Kim, D.S. Fieno, and T.B. Parrish et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
40. K. Malliaras, Y. Zhang, and J. Seinfeld et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart EMBO Mol Med 5 2013 191 209
41. K. Malliaras, and E. Marbán Cardiac cell therapy: where we've been, where we are, and where we should be headed Br Med Bull 98 2011 161 185
42. M. Tendera, W. Wojakowski, and W. Ruzyllo et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial Eur Heart J 30 2009 1313 1321
43. D.R. Davis, R. Ruckdeschel Smith, and E. Marbán Human cardiospheres are a source of stem cells with cardiomyogenic potential Stem Cells 28 2010 903 904
44. I. Chimenti, R.R. Smith, and T.S. Li et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice Circ Res 106 2010 971 980
45. E. Tseliou, S. Pollan, and K. Malliaras et al. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains J Am Coll Cardiol 61 2013 1108 1119
46. M.S. Penn, F.O. Mendelsohn, and G.L. Schaer et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure Circ Res 112 2013 816 825
47. E. Yaniz-Galende, J. Chen, and E. Chemaly et al. Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells Circ Res 111 2012 1434 1445
48. V.F. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692
49. J.M. Hare, J.E. Fishman, and G. Gerstenblith et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial JAMA 308 2012 2369 2379
50. Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR) (NCT01458405). Available at: http://clinicaltrials.gov/ct2/show/NCT01458405? term=allstar&rank=1. Accessed January 13, 2013.